Lv1
40 积分 2026-07-03 加入
A novel dual targeted antibacterial agent for Helicobacter pylori
2个月前
已完结
Rifasutenizol-based triple therapy for Helicobacter pylori infection
2个月前
已完结
Safety, pharmacokinetics, and efficacy of rifasutenizol, a novel dual-targeted antibacterial agent in healthy participants and patients in China with Helicobacter pylori infection: four randomised clinical trials
2个月前
已完结
皖公网安备34019202002308
